How far would you go to reshape medicine?
Dr. Janakan Krishnarajah has led over 100 clinical trials, transitioning from bedside physician to a biotech disruptor. On this episode, he reveals that turning point—and the early challenge that redefined his path.
Next: he developed Wafermine, the world’s first sublingual ketamine wafer for acute pain—a bold alternative in the opioid era. How did he convince skeptics this wasn’t anesthesia or recreational use, but revolutionary pain management? We dig into the story behind the innovation and the FDA and EMA approvals that made Phase 3 trials possible.
And then came Xativa, a freeze-dried medicinal cannabis wafer. We explore how iX Biopharma pushed this disruptive therapy into mainstream medicine—despite regulatory headwinds and stigma.
This isn't all success: Dr. Krishnarajah opens up about a major setback when dreaming big went wrong—and the lessons that changed his leadership style. You’ll hear why he lives by “pursue life with your whole heart, without regrets,” and how that mantra shapes innovation and company culture at iX Biopharma.
From the explosive growth of the global medicinal cannabis market to the rise of longevity medicine, this conversation spans the past, present, and future of healthcare. What does sublingual NAD for longevity really hold? Is it breakthrough or overhyped? Only one way to find out.
Want the full story behind modern medicine’s boldest bets? Tune in now.
Learn more about Dr. Janakan Krishnarajah and iX Biopharma:
We are two sports chiropractors, seeking knowledge from some of the best resources in the world of health. From our perspective, health is more than just “Crackin Backs” but a deep dive into physical, mental, and nutritional well-being philosophies.
Join us as we talk to some of the greatest minds and discover some of the most incredible gems you can use to maintain a higher level of health. Crackin Backs Podcast